Hypoprothrombinemic potential of moxalactam.
D002435:Cefamandole / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects*; D002513:Cephamycins / Q000009:adverse effects*; D006801:Humans; D007020:Hypoprothrombinemias / Q000139:chemically induced*; D009070:Moxalactam
D002511:Cephalosporins; D002513:Cephamycins; D002435:Cefamandole; D009070:Moxalactam